Clostridium perfringens Type A Isolates of Animal Origin with Decreased Susceptibility to Metronidazole Show Extensive Genetic Diversity.
Sign Up to like & getrecommendations! Published in 2017 at "Microbial drug resistance"
DOI: 10.1089/mdr.2016.0277
Abstract: Metronidazole (MTZ) is a first-line drug for the treatment of human infections caused by anaerobic bacteria. Although most Clostridium perfringens isolates are susceptible to metronidazole, a number of strains with decreased susceptibility have been obtained… read more here.
Keywords: diversity; susceptibility metronidazole; genetic diversity; clostridium perfringens ... See more keywords